River Road Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-64,152
| Closed | -$3.89M | – | 179 |
|
|
2026
Q1 | $3.89M | Sell |
64,152
-31,655
| -33% | -$1.85M | 0.04% | 164 |
|
|
2025
Q4 | $5.17M | Sell |
95,807
-3,601
| -4% | -$173K | 0.06% | 160 |
|
|
2025
Q3 | $4.48M | Sell |
99,408
-883
| -0.9% | -$41.2K | 0.05% | 168 |
|
|
2025
Q2 | $4.34M | Sell |
100,291
-67,650
| -40% | -$3.32M | 0.06% | 173 |
|
|
2025
Q1 | $10.2M | Sell |
167,941
-14,543
| -8% | -$848K | 0.14% | 124 |
|
|
2024
Q4 | $10.3M | Sell |
182,484
-33,839
| -16% | -$1.89M | 0.14% | 119 |
|
|
2024
Q3 | $11.2M | Sell |
216,323
-4,151
| -2% | -$195K | 0.15% | 118 |
|
|
2024
Q2 | $9.16M | Sell |
220,474
-62,053
| -22% | -$2.78M | 0.13% | 126 |
|
|
2024
Q1 | $15.3M | Sell |
282,527
-75,549
| -21% | -$3.85M | 0.21% | 114 |
|
|
2023
Q4 | $18.4M | Sell |
358,076
-8,526
| -2% | -$448K | 0.26% | 102 |
|
|
2023
Q3 | $21.3M | Sell |
366,602
-12,752
| -3% | -$781K | 0.3% | 98 |
|
|
2023
Q2 | $24.3M | Sell |
379,354
-20,718
| -5% | -$1.39M | 0.33% | 89 |
|
|
2023
Q1 | $27.7M | Buy |
400,072
+16,887
| +4% | +$1.19M | 0.38% | 84 |
|
|
2022
Q4 | $27.6M | Sell |
383,185
-21,645
| -5% | -$1.63M | 0.38% | 89 |
|
|
2022
Q3 | $28.8M | Sell |
404,830
-1,485
| -0.4% | -$108K | 0.43% | 80 |
|
|
2022
Q2 | $31.3M | Sell |
406,315
-6,918
| -2% | -$527K | 0.44% | 73 |
|
|
2022
Q1 | $30.2M | Sell |
413,233
-854,683
| -67% | -$57.4M | 0.33% | 82 |
|
|
2021
Q4 | $79.1M | Sell |
1,267,916
-345,538
| -21% | -$20.3M | 0.84% | 44 |
|
|
2021
Q3 | $95.5M | Sell |
1,613,454
-223,275
| -12% | -$14.7M | 1.06% | 33 |
|
|
2021
Q2 | $123M | Sell |
1,836,729
-205,935
| -10% | -$13.4M | 1.32% | 22 |
|
|
2021
Q1 | $129M | Sell |
2,042,664
-51,575
| -2% | -$3.21M | 1.56% | 19 |
|
|
2020
Q4 | $130M | Buy |
2,094,239
+44,618
| +2% | +$2.74M | 1.84% | 16 |
|
|
2020
Q3 | $124M | Buy |
2,049,621
+332,859
| +19% | +$20M | 2.02% | 13 |
|
|
2020
Q2 | $101M | Buy |
1,716,762
+652,857
| +61% | +$39M | 1.74% | 15 |
|
|
2020
Q1 | $59.3M | Sell |
1,063,905
-48,022
| -4% | -$2.94M | 1.33% | 20 |
|
|
2019
Q4 | $71.4M | Buy |
1,111,927
+194,210
| +21% | +$11.1M | 1.13% | 26 |
|
|
2019
Q3 | $46.5M | Buy |
917,717
+177,620
| +24% | +$8.35M | 0.88% | 45 |
|
|
2019
Q2 | $33.6M | Sell |
740,097
-52,644
| -7% | -$2.45M | 0.65% | 65 |
|
|
2019
Q1 | $37.8M | Buy |
+792,741
| New | +$39.5M | 0.84% | 53 |
|
Other funds holding BMY
River Road Asset Management's BMY Position: Q2 2026 in Review
River Road Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 64,152 shares — an estimated $3.89M sold.
River Road Asset Management first reported a position in BMY in Q1 2019 and held it in 29 quarters. The position peaked at $130M in Q4 2020. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- River Road Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
- River Road Asset Management sold 64,152 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.89M.
- River Road Asset Management first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 29 quarters.
- River Road Asset Management's Bristol-Myers Squibb position peaked at $130M in Q4 2020.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on River Road Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.